Drugs / FERUMOXIDES
FERUMOXIDES
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00972946 | Sep 2009 → Jan 2012 | — | University of Edinburgh | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FERUMOXIDES | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201502 ↗ |
| Known as | AMI-25 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201502 ↗ |
| Known as | Endorem | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00972946 ↗ |
| Known as | Feridex i.v. | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201502 ↗ |
| Modality | Diagnostic / imaging agent | “MRI contrast agent Endorem (superparamagnetic particles of iron oxide)” NCT00972946 ↗ |
| Route | Intravenous | “single dose, intravenous” NCT00972946 ↗ |